Operating Lease, Right-of-Use Asset of Aptose Biosciences Inc. from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aptose Biosciences Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • Aptose Biosciences Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $277,000, a 58% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Aptose Biosciences Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $277,000 -$387,000 -58% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $377,000 -$379,000 -50% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $475,000 -$375,000 -44% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $571,000 -$372,000 -39% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $664,000 -$371,000 -36% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $756,000 -$370,000 -33% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $850,000 -$368,000 -30% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $943,000 -$354,000 -27% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $1,035,000 +$815,000 +370% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $1,126,000 +$795,000 +240% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $1,218,000 +$776,000 +176% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $1,297,000 +$832,000 +179% 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 $220,000 -$359,000 -62% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $331,000 -$367,000 -53% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $442,000 -$366,000 -45% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $465,000 -$460,000 -50% 31 Dec 2021 10-K 24 Mar 2023 2022 FY
Q3 2021 $579,000 -$462,000 -44% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $698,000 -$449,000 -39% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $808,000 -$454,000 -36% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $925,000 -$451,000 -33% 31 Dec 2020 10-K 22 Mar 2022 2021 FY
Q3 2020 $1,041,000 -$450,000 -30% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $1,147,000 -$426,000 -27% 30 Jun 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 $1,262,000 -$418,000 -25% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 $1,376,000 -$194,000 -12% 31 Dec 2019 10-K 23 Mar 2021 2020 FY
Q3 2019 $1,491,000 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $1,573,000 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $1,680,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $1,570,000 01 Jan 2019 10-K 23 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.